Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Menendez

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|June 10, 2014
p53 vs. ISG15: stop, you're killing meDaniel Menendez, Carl W Anderson
Discovery Medicine|July 31, 2010
Potentiating the p53 networkDaniel Menendez, Alberto Inga, Michael A Resnick
Molecular and Cellular Biology|March 2, 2006
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genesDaniel Menendez, Alberto Inga, Michael A Resnick
Cell Cycle (Georgetown, Tex.)|October 26, 2012
Transactivation by low and high levels of human p53 reveals new physical rules of engagement and novel super-transactivation sequencesDaniel Menendez, Michael A Resnick, Tali Haran
Nature Reviews. Cancer|September 25, 2009
The expanding universe of p53 targetsDaniel Menendez, Alberto Inga, Michael A Resnick
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequencesDaniel Menendez, Alberto Inga, Michael A Resnick
Cancer Research|June 8, 2012
The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cellsMaria Shatz, Daniel Menendez, Michael A Resnick
Current Opinion in Oncology|November 15, 2012
Interactions between the tumor suppressor p53 and immune responsesDaniel Menendez, Maria Shatz, Michael A Resnick
Cell Cycle (Georgetown, Tex.)|December 9, 2014
A new inflammatory role for p53 in human macrophagesJulie M Lowe, Daniel Menendez, Michael B Fessler
Oncotarget|July 30, 2015
p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathwaysMaria Shatz, Igor Shats, Daniel Menendez, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|June 10, 2014
p53 vs. ISG15: stop, you're killing meDaniel Menendez, Carl W Anderson
Discovery Medicine|July 31, 2010
Potentiating the p53 networkDaniel Menendez, Alberto Inga, Michael A Resnick
Molecular and Cellular Biology|March 2, 2006
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genesDaniel Menendez, Alberto Inga, Michael A Resnick
Cell Cycle (Georgetown, Tex.)|October 26, 2012
Transactivation by low and high levels of human p53 reveals new physical rules of engagement and novel super-transactivation sequencesDaniel Menendez, Michael A Resnick, Tali Haran
Nature Reviews. Cancer|September 25, 2009
The expanding universe of p53 targetsDaniel Menendez, Alberto Inga, Michael A Resnick
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequencesDaniel Menendez, Alberto Inga, Michael A Resnick
Cancer Research|June 8, 2012
The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cellsMaria Shatz, Daniel Menendez, Michael A Resnick
Current Opinion in Oncology|November 15, 2012
Interactions between the tumor suppressor p53 and immune responsesDaniel Menendez, Maria Shatz, Michael A Resnick
Cell Cycle (Georgetown, Tex.)|December 9, 2014
A new inflammatory role for p53 in human macrophagesJulie M Lowe, Daniel Menendez, Michael B Fessler
Oncotarget|July 30, 2015
p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathwaysMaria Shatz, Igor Shats, Daniel Menendez, et al.
Pageof 5